XML 36 R29.htm IDEA: XBRL DOCUMENT v3.25.3
Nature of Business - Additional Information (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Feb. 28, 2025
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Cash, cash equivalents and short-term investments   $ 14,100           $ 14,100    
Net Income (Loss)   (7,804) $ (5,956) $ (5,042) $ (5,618) $ (3,954) $ 130 (18,802) $ (9,442)  
Accumulated deficit   $ (178,566)           (178,566)   $ (159,764)
Consideration Transferred               29,400    
Proceeds from issuance of notes               $ 9,664 $ 0  
Loan Agreement                    
Gross proceeds from loan agreement $ 10,000                  
CalciMedica                    
Percentage of ownership of common stock   72.00%           72.00%    
Graybug                    
Percentage of ownership of common stock   28.00%           28.00%    
Convertible Debt [Member]                    
Proceeds from issuance of notes               $ 18,300    
Preferred and Common stock [Member]                    
Total net proceeds               $ 142,500